The toxic effects of combined cisplatin/docetaxel therapy cycles on erythroid and granulocytic hematopoietic lineages as well as their intercycle recovery were examined in patients with stage III-IV non-small-cell lung carcinoma. Responsiveness of the blood system to this therapy remained at a high level. Combined therapy pronouncedly activated the key elements of the erythroid and granulocytic hematopoietic lineages leading to accumulation of immature and mature myelokaryocytes in the bone marrow, enlargement of the medullary pool of mature neutrophils, and increase in the count of medullary erythroid and granulocytic precursor cells under conditions of their accelerated maturation.
Similar content being viewed by others
References
Bagrova SG, Bychkov MB, Gorbunova VA, Kuzminov AE, Naskhletashvili DR. Comparative evaluation of different regimen of platinum-based chemotherapy in treatment of advanced small cell lung cancer (experience of chemotherapy department N. N. Blokhin Russian Cancer Research Center RAMS). Ross. Onkol. Zh. 2013(2):4-10. Russian.
Goldberg ED, Dygai AM, Zhdanov VV, Zyuz’kov GN, Gyr’yantseva LA, Pershina OV, Simanina EV, Skurikhin EG, Stavrova LA, Udut EV, Minakova MYu, Khrichkova TYu, Firsova TV.The theory of hematopoiesis regulation and creation of new drugs for the therapy of blood system pathology on its basis. Bull. Exp. Biol. Med. 2008;(Suppl. 2):6-13. Russian.
Zhdanov VV, Gol’dberg VE, Khrichkova TYu, Matyash MG, Gur’yantseva LA, Simolina EI, Vysotskaya VV, Suslov NI, Popova NO, Dygai AM. The hemostimulant effect of cropanol under the conditions of myelosuppression induced by cytostatic agents. Eskp. Klin. Farmakol. 2002;65(6):37-40. Russian.
Koroleva IA, Kopp MV, Shaplygin LV. Prophylaxis and treatment of chemotherapy-induced neutropenia and anemia. Klin. Onkogenatol. 2012;5(3):246-254. Russian.
Pokrovskaya OS. Mechanism of action and clinical activity of CXCR4 antagonist Plerixafor in stem cell mobilization. Klin. Onkogenatol. 2012;5(4):371-379. Russian.
Pokrovsky VS, Treshalina HM, Bychkov MB. Development of combined chemotherapy in disseminated small-cell lung cancer treatment. Ross. Bioter. Zh. 2009;8(3):61-68. Russian.
Lung Cancer. Logrigan P, ed. Moscow, 2009. Russian.
Reutova EV, Marenich AF. Non-small cell lung cancer: the prospects of chemotherapy. Prakt. Pul’monol. 2011(3):1-10. Russian.
Khrichkova TYu, Goldberg VE, Popova NO, Simolina EI, Belevich YuV, Zhdanov VV, Miroshnichenko LA, Udut EV, Simanina EV. Mechanisms of activation of hematopoietic recovery due to filgastrim in breast cancer patients receiving chemotherapy with doxorubicin/docetaxel. Sib. Onkol. Zh. 2015(6):46-51. Russian.
Dygai AM, Zhdanov VV, Miroshnichenko LA, Zyuz’kov GN, Udut EV, Simanina EV, Stavrova LA, Khrichkova TY, Agafonov VI. Comparison of specific activity of granulocytopoiesis stimulators after treatment with cytostatics with different mechanisms of action. Bull. Exp. Biol. Med. 2013;155(5):631-635.
Fennell DA, Summers Y, Cadranel J, Benepal T, Christoph DC, Lal R, Das M, Maxwell F, Visseren-Grul C, Ferry D. Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer. Cancer Treat. Rev. 2016;44:42-50.
Fiala MA, Park S, Slade M, DiPersio JF, Stockerl-Goldstein KE. Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation. Transfusion. 2016. 2016;56(9):2331-2335.
Miroshnichenko LA, Shdanov VV, Zyuz’kov GN, Simanina EV, Stavrova LA, Udut EV, Khrichkova TY, Minakova MY, Goldberg VE, Dygai AM. Mechanisms of hemostimulating effects of granulocytic CSF and pantohematogen under conditions of cytostatic myelosuppression. Bull. Exp. Biol. Med. 2011;150(6):702-706.
Shen G, Bian G, Yu H, Gao M, Kang D, Shen G, Hu S. Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials. Mol. Clin. Oncol. 2014;2(1):146-150.
Zhdanov VV, Gur’yantseva LA, Udut EV, Khrichkova TY, Simanina EV, Gol’dberg VE. Function of hemopoietic stem cells under conditions of cytostatic myelosupression and treatment with hemostimulators. Bull. Exp. Biol. Med. 2005;140(5):631-634.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 4, pp. 466-472, April 2017
Rights and permissions
About this article
Cite this article
Goldberg, V.E., Polyakova, T.Y., Popova, N.O. et al. Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma. Bull Exp Biol Med 163, 469–474 (2017). https://doi.org/10.1007/s10517-017-3830-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-017-3830-y